Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Linezolid and Glucose Injection

Approval Number

国药准字H20243447

Company安徽双鹤药业有限责任公司

Registration Date

April 7, 2024

Drug Information

Generic Name

利奈唑胺葡萄糖注射液

Dosage Form

注射剂

Strength

100ml:利奈唑胺0.2g与葡萄糖(按C₆H₁₂O₆计)4.57g

Drug Type

化学药品

Registration Date

April 7, 2024

Company Information

Applicant Company

Company Name安徽双鹤药业有限责任公司

Company Address

安徽省芜湖市三山经济开发区天成路2号

Manufacturing Company

Company Name安徽双鹤药业有限责任公司

Company Address

安徽省芜湖市三山经济开发区天成路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利奈唑胺葡萄糖注射液 - NMPA 批准文号 | MedPath